IGSF3
Basic information
Region (hg38): 1:116574399-116667755
Links
Phenotypes
GenCC
Source:
- familial congenital nasolacrimal duct obstruction (Supportive), mode of inheritance: AR
- familial congenital nasolacrimal duct obstruction (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lacrimal duct defect | AR | Audiologic/Otolaryngologic | Awareness may allow early surgical treatemnt of nasolacrimal duct obstruction/dacryocystocele, which may be beneficial to avoid complications | Audiologic/Otolaryngologic | 24372406 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGSF3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 108 | 117 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 2 | 108 | 13 | 4 |
Variants in IGSF3
This is a list of pathogenic ClinVar variants found in the IGSF3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-116577328-G-C | not specified | Uncertain significance (Dec 09, 2023) | ||
1-116577358-C-A | not specified | Uncertain significance (Mar 15, 2024) | ||
1-116577443-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
1-116577448-T-C | not specified | Uncertain significance (Jun 04, 2024) | ||
1-116577466-A-T | not specified | Uncertain significance (Oct 26, 2021) | ||
1-116577470-T-C | not specified | Uncertain significance (Sep 29, 2022) | ||
1-116577527-C-T | not specified | Uncertain significance (Apr 28, 2023) | ||
1-116577532-T-C | not specified | Uncertain significance (Dec 20, 2023) | ||
1-116579406-C-T | not specified | Likely benign (Sep 20, 2023) | ||
1-116579407-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
1-116579421-G-A | not specified | Uncertain significance (May 04, 2022) | ||
1-116579426-C-G | not specified | Uncertain significance (Jun 05, 2023) | ||
1-116579442-C-T | not specified | Uncertain significance (Jun 26, 2024) | ||
1-116579483-A-G | IGSF3-related disorder | Likely benign (Sep 17, 2019) | ||
1-116579508-T-C | IGSF3-related disorder | Benign (Oct 21, 2019) | ||
1-116579512-G-A | not specified | Uncertain significance (Nov 15, 2024) | ||
1-116579547-G-A | not specified | Uncertain significance (Mar 21, 2024) | ||
1-116579620-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
1-116579650-C-T | not specified | Uncertain significance (Jul 07, 2022) | ||
1-116579656-C-CGTT | IGSF3-related disorder | Benign (Oct 07, 2019) | ||
1-116579662-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
1-116579662-CG-C | Likely pathogenic (Feb 26, 2020) | |||
1-116579663-G-C | IGSF3-related disorder | Benign (Sep 26, 2019) | ||
1-116579666-G-C | IGSF3-related disorder | Benign (Dec 31, 2019) | ||
1-116579681-C-G | not specified | Uncertain significance (Feb 02, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IGSF3 | protein_coding | protein_coding | ENST00000369483 | 11 | 93345 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.265 | 0.735 | 125706 | 0 | 42 | 125748 | 0.000167 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.77 | 631 | 769 | 0.820 | 0.0000497 | 7927 |
Missense in Polyphen | 150 | 231.49 | 0.64798 | 2404 | ||
Synonymous | -1.23 | 353 | 325 | 1.09 | 0.0000222 | 2451 |
Loss of Function | 5.34 | 13 | 56.1 | 0.232 | 0.00000319 | 530 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000590 | 0.000586 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000215 | 0.000202 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.502
- rvis_EVS
- -1.34
- rvis_percentile_EVS
- 4.65
Haploinsufficiency Scores
- pHI
- 0.558
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.604
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.353
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Igsf3
- Phenotype
Gene ontology
- Biological process
- lacrimal gland development
- Cellular component
- cell surface;integral component of membrane
- Molecular function
- molecular_function